As with the commercialization agreement for Japan, revenues from all related product sales will be shared equally between Cytori and Green Hospital Supply.
The StemSource cell bank is being commercialized to hospitals in Japan, Korea, Taiwan and Thailand by Green Hospital Supply, in partnership with Cytori.
The foundation of the StemSource cell bank is Cytori’s proprietary Celution 900 system, which automates the separation and concentration of stem and regenerative cells residing within adipose tissue so they may be prepared for cryopreservation.
Seijiro Shirahama, president of Cytori Asia Pacific, said: “With Green Hospital Supply’s experience and knowledge of the region, we are able to take advantage of the existing product infrastructure to expand the revenue potential for the StemSource cell bank.”